AHFS Patient Medication Information Update – April 2016

The April update to the AHFS Patient Medication Information (PMI) database has been published. Highlights of this month’s update include:

New AHFS PMI Monographs

  • Buprenorphine Buccal (Belbuca®), indicated for severe chronic pain
  • Emtricitabine/Rilpivirine/Tenofovir (Complera®), indicated for HIV infection
  • Lesinurad (Zurampic®), indicated for hyperuricemia in people with gout
  • Posaconazole Injection (Noxafil®), indicated for prevention of fungal infections in people with weakened ability to fight infections

FDA MedWatch Alerts

  • New safety warnings for opioids
  • Risk of heart failure for alogliptin and saxagliptin
  • New safety warning for metformin in patients with reduced kidney function

Drug Information News

RSS ASHP Health-System Pharmacy News

Visit AHFS at HIMSS16

The new AHFS® Clinical Drug Information is your comprehensive, interactive treatment and drug therapy solution to optimize your time and advance care.

If you’re attending HIMSS16, visit the AHFS booth, #10712, and get an exclusive preview of AHFS Clinical Drug Information, the next big thing for easy access to real-time drug information and updates.

Sign up to be a beta tester in the coming months, and register for a chance to win a Fitbit Charge HR! fitbit

1 15 16 17 18